Sign in
LBO-03 - A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of cilofexor in patients with non-cirrhotic primary sclerosing cholangitis (PRIMIS)
Journal article   Peer reviewed

LBO-03 - A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of cilofexor in patients with non-cirrhotic primary sclerosing cholangitis (PRIMIS)

Michael Trauner, Cynthia Levy, Atsushi Tanaka, Zachary Goodman, Douglas Thorburn, Deepak Joshi, Kimmo Salminen, Kidist Yimam, Hiroyuki Isayama, Aldo J Montano-Loza, …
Journal of hepatology, Vol.78, pp.S12-S13
2023-06

Metrics

1 Record Views

Details